Krüppel-Like Factor-4 Transcriptionally Regulates VE-Cadherin Expression and Endothelial Barrier Function

RATIONALE:Vascular endothelial (VE)-cadherin localized at adherens junctions (AJs) regulates endothelial barrier function. Because WNT (wingless) signaling-induced activation of the transcription factor Krüppel-like factor (KLF)4 may have an important role in mediating the expression of VE-cadherin...

Full description

Saved in:
Bibliographic Details
Published inCirculation research Vol. 107; no. 8; pp. 959 - 966
Main Authors Cowan, Colleen E, Kohler, Erin E, Dugan, Tracey A, Mirza, M Kamran, Malik, Asrar B, Wary, Kishore K
Format Journal Article
LanguageEnglish
Published Hagerstown, MD American Heart Association, Inc 15.10.2010
Lippincott Williams & Wilkins
Subjects
Online AccessGet full text

Cover

Loading…
Abstract RATIONALE:Vascular endothelial (VE)-cadherin localized at adherens junctions (AJs) regulates endothelial barrier function. Because WNT (wingless) signaling-induced activation of the transcription factor Krüppel-like factor (KLF)4 may have an important role in mediating the expression of VE-cadherin and AJ integrity, we studied the function of KLF4 in regulating VE-cadherin expression and the control of endothelial barrier function. OBJECTIVE:The goal of this study was to determine the transcriptional role of KLF4 in regulating VE-cadherin expression and endothelial barrier function. METHODS AND RESULTS:Expression analysis, microscopy, chromatin immunoprecipitation, electrophoretic mobility shift assays, and VE-cadherin–luciferase reporter experiments demonstrated that KLF4 interacted with specific domains of VE-cadherin promoter and regulated the expression of VE-cadherin at AJs. KLF4 knockdown disrupted the endothelial barrier, indicating that KLF4 is required for normal barrier function. In vivo studies in mice showed augmented lipopolysaccharide-induced lung injury and pulmonary edema following Klf4 depletion. CONCLUSION:Our data show the key role of KLF4 in the regulation of VE-cadherin expression at the level of the AJs and in the acquisition of VE-cadherin–mediated endothelial barrier function. Thus, KLF4 maintains the integrity of AJs and prevents vascular leakage in response to inflammatory stimuli.
AbstractList Vascular endothelial (VE)-cadherin localized at adherens junctions (AJs) regulates endothelial barrier function. Because WNT (wingless) signaling-induced activation of the transcription factor Krüppel-like factor (KLF)4 may have an important role in mediating the expression of VE-cadherin and AJ integrity, we studied the function of KLF4 in regulating VE-cadherin expression and the control of endothelial barrier function. The goal of this study was to determine the transcriptional role of KLF4 in regulating VE-cadherin expression and endothelial barrier function. Expression analysis, microscopy, chromatin immunoprecipitation, electrophoretic mobility shift assays, and VE-cadherin-luciferase reporter experiments demonstrated that KLF4 interacted with specific domains of VE-cadherin promoter and regulated the expression of VE-cadherin at AJs. KLF4 knockdown disrupted the endothelial barrier, indicating that KLF4 is required for normal barrier function. In vivo studies in mice showed augmented lipopolysaccharide-induced lung injury and pulmonary edema following Klf4 depletion. Our data show the key role of KLF4 in the regulation of VE-cadherin expression at the level of the AJs and in the acquisition of VE-cadherin-mediated endothelial barrier function. Thus, KLF4 maintains the integrity of AJs and prevents vascular leakage in response to inflammatory stimuli.
RATIONALEVascular endothelial (VE)-cadherin localized at adherens junctions (AJs) regulates endothelial barrier function. Because WNT (wingless) signaling-induced activation of the transcription factor Krüppel-like factor (KLF)4 may have an important role in mediating the expression of VE-cadherin and AJ integrity, we studied the function of KLF4 in regulating VE-cadherin expression and the control of endothelial barrier function. OBJECTIVEThe goal of this study was to determine the transcriptional role of KLF4 in regulating VE-cadherin expression and endothelial barrier function. METHODS AND RESULTSExpression analysis, microscopy, chromatin immunoprecipitation, electrophoretic mobility shift assays, and VE-cadherin-luciferase reporter experiments demonstrated that KLF4 interacted with specific domains of VE-cadherin promoter and regulated the expression of VE-cadherin at AJs. KLF4 knockdown disrupted the endothelial barrier, indicating that KLF4 is required for normal barrier function. In vivo studies in mice showed augmented lipopolysaccharide-induced lung injury and pulmonary edema following Klf4 depletion. CONCLUSIONOur data show the key role of KLF4 in the regulation of VE-cadherin expression at the level of the AJs and in the acquisition of VE-cadherin-mediated endothelial barrier function. Thus, KLF4 maintains the integrity of AJs and prevents vascular leakage in response to inflammatory stimuli.
Rationale: Vascular endothelial (VE)-cadherin localized at adherens junctions (AJs) regulates endothelial barrier function. Because WNT (wingless) signaling-induced activation of the transcription factor Krüppel-like factor (KLF)4 may have an important role in mediating the expression of VE-cadherin and AJ integrity, we studied the function of KLF4 in regulating VE-cadherin expression and the control of endothelial barrier function. Objective: The goal of this study was to determine the transcriptional role of KLF4 in regulating VE-cadherin expression and endothelial barrier function. Methods and Results: Expression analysis, microscopy, chromatin immunoprecipitation, electrophoretic mobility shift assays, and VE-cadherin–luciferase reporter experiments demonstrated that KLF4 interacted with specific domains of VE-cadherin promoter and regulated the expression of VE-cadherin at AJs. KLF4 knockdown disrupted the endothelial barrier, indicating that KLF4 is required for normal barrier function. In vivo studies in mice showed augmented lipopolysaccharide-induced lung injury and pulmonary edema following Klf4 depletion. Conclusion: Our data show the key role of KLF4 in the regulation of VE-cadherin expression at the level of the AJs and in the acquisition of VE-cadherin–mediated endothelial barrier function. Thus, KLF4 maintains the integrity of AJs and prevents vascular leakage in response to inflammatory stimuli.
RATIONALE:Vascular endothelial (VE)-cadherin localized at adherens junctions (AJs) regulates endothelial barrier function. Because WNT (wingless) signaling-induced activation of the transcription factor Krüppel-like factor (KLF)4 may have an important role in mediating the expression of VE-cadherin and AJ integrity, we studied the function of KLF4 in regulating VE-cadherin expression and the control of endothelial barrier function. OBJECTIVE:The goal of this study was to determine the transcriptional role of KLF4 in regulating VE-cadherin expression and endothelial barrier function. METHODS AND RESULTS:Expression analysis, microscopy, chromatin immunoprecipitation, electrophoretic mobility shift assays, and VE-cadherin–luciferase reporter experiments demonstrated that KLF4 interacted with specific domains of VE-cadherin promoter and regulated the expression of VE-cadherin at AJs. KLF4 knockdown disrupted the endothelial barrier, indicating that KLF4 is required for normal barrier function. In vivo studies in mice showed augmented lipopolysaccharide-induced lung injury and pulmonary edema following Klf4 depletion. CONCLUSION:Our data show the key role of KLF4 in the regulation of VE-cadherin expression at the level of the AJs and in the acquisition of VE-cadherin–mediated endothelial barrier function. Thus, KLF4 maintains the integrity of AJs and prevents vascular leakage in response to inflammatory stimuli.
Author Wary, Kishore K
Mirza, M Kamran
Kohler, Erin E
Dugan, Tracey A
Cowan, Colleen E
Malik, Asrar B
AuthorAffiliation From the Department of Pharmacology, University of Illinois, Chicago
AuthorAffiliation_xml – name: From the Department of Pharmacology, University of Illinois, Chicago
Author_xml – sequence: 1
  givenname: Colleen
  surname: Cowan
  middlename: E
  fullname: Cowan, Colleen E
  organization: From the Department of Pharmacology, University of Illinois, Chicago
– sequence: 2
  givenname: Erin
  surname: Kohler
  middlename: E
  fullname: Kohler, Erin E
– sequence: 3
  givenname: Tracey
  surname: Dugan
  middlename: A
  fullname: Dugan, Tracey A
– sequence: 4
  givenname: M
  surname: Mirza
  middlename: Kamran
  fullname: Mirza, M Kamran
– sequence: 5
  givenname: Asrar
  surname: Malik
  middlename: B
  fullname: Malik, Asrar B
– sequence: 6
  givenname: Kishore
  surname: Wary
  middlename: K
  fullname: Wary, Kishore K
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23351775$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/20724706$$D View this record in MEDLINE/PubMed
BookMark eNpVkd9u0zAUhy00xLrBI4Byg7jKOP4XJzdIpWq3iUpIZXBrOcnp6s11Mjth7N12x4vhqmUD-cI69nd-PtZ3Qo5855GQtxTOKC3ox9nlaraaf5teTFMNZ4xWsmIvyIRKJnIhFT0iEwCocsU5HJOTGG8AqOCsekWOGSgmFBQTcvMl_H7se3T50t5itjDN0IVcZFfB-NgE2w-288a5h2yF16MzA8bsxzyfmXaDwfps_qsPGGOCMuPbbO7bbtigs8Zln00IFkO2GH2zS3lNXq6Ni_jmsJ-S74v51ewiX349v5xNl3kjJZW5LLEulFAtYo20lqJuq7IEXqpKKFbVwIxSlBe8gIa2IGqBRV2rqmAVB1NX_JR82uf2Y73FtkE_BON0H-zWhAfdGav_v_F2o6-7n5oDLRVACvhwCAjd3Yhx0FsbG3TOeOzGqJUsS67SQImUe7IJXYwB10-vUNA7TfpZU6pB7zWlvnf_jvjU9ddLAt4fABMb49bJRmPjM8e5pErJxIk9d9-5AUO8deM9Br1B44aNTv4hfYrlDOhuSch3R5L_Adk7rwk
CODEN CIRUAL
CitedBy_id crossref_primary_10_1016_j_bbrc_2017_11_205
crossref_primary_10_1093_cvr_cvv175
crossref_primary_10_3390_cancers13205135
crossref_primary_10_1186_s12987_023_00424_5
crossref_primary_10_3390_metabo13030448
crossref_primary_10_1007_s00011_015_0907_9
crossref_primary_10_1161_JAHA_118_010690
crossref_primary_10_1111_bpa_12831
crossref_primary_10_3389_fmolb_2021_725274
crossref_primary_10_3390_biomedicines11041216
crossref_primary_10_1016_j_bbalip_2020_158760
crossref_primary_10_1038_s41598_017_14602_7
crossref_primary_10_1186_s12974_016_0523_9
crossref_primary_10_1093_carcin_bgad013
crossref_primary_10_1074_jbc_M117_814376
crossref_primary_10_1152_ajpregu_00135_2020
crossref_primary_10_1038_ncomms10521
crossref_primary_10_1016_j_freeradbiomed_2024_02_024
crossref_primary_10_1016_j_gene_2017_02_025
crossref_primary_10_1186_s12967_020_02342_8
crossref_primary_10_1016_j_avsg_2021_04_040
crossref_primary_10_1172_jci_insight_91700
crossref_primary_10_1089_scd_2015_0039
crossref_primary_10_3390_jcm13071994
crossref_primary_10_1016_j_gendis_2016_02_003
crossref_primary_10_1096_fj_11_182410
crossref_primary_10_3389_fimmu_2016_00389
crossref_primary_10_1371_journal_pone_0085549
crossref_primary_10_1371_journal_pone_0107463
crossref_primary_10_1074_jbc_M114_582809
crossref_primary_10_1096_fj_202100688RRR
crossref_primary_10_1111_micc_12226
crossref_primary_10_1016_j_biocel_2014_02_010
crossref_primary_10_1165_rcmb_2014_0024OC
crossref_primary_10_1016_j_avsg_2020_04_015
crossref_primary_10_1080_10985549_2023_2210030
crossref_primary_10_3390_molecules28176202
crossref_primary_10_1074_jbc_M113_530956
crossref_primary_10_1002_stem_1658
crossref_primary_10_1002_stem_1977
crossref_primary_10_1165_rcmb_2012_0026OC
crossref_primary_10_1007_s12035_017_0556_9
crossref_primary_10_1016_j_yjmcc_2019_11_151
crossref_primary_10_1016_j_cca_2020_11_002
crossref_primary_10_1016_j_cellsig_2022_110466
crossref_primary_10_1084_jem_20221388
crossref_primary_10_1371_journal_pone_0152166
crossref_primary_10_1371_journal_pone_0176496
crossref_primary_10_1038_s41419_020_2228_3
crossref_primary_10_3389_fcell_2022_1003028
crossref_primary_10_1093_cvr_cvac151
crossref_primary_10_2478_jtim_2018_0019
crossref_primary_10_4161_cam_27330
crossref_primary_10_3390_genes11090966
crossref_primary_10_1016_j_ajpath_2012_11_022
crossref_primary_10_1186_1476_4598_10_51
crossref_primary_10_1161_CIRCULATIONAHA_117_027646
crossref_primary_10_1074_jbc_M114_618694
crossref_primary_10_1160_TH12_09_0678
crossref_primary_10_1161_JAHA_113_000622
crossref_primary_10_12659_MSM_897266
crossref_primary_10_1146_annurev_pathol_012615_044506
crossref_primary_10_15252_emmm_201505433
crossref_primary_10_1534_g3_117_300507
crossref_primary_10_1016_j_biomaterials_2015_04_055
crossref_primary_10_1182_blood_2010_07_295261
crossref_primary_10_1007_s00395_012_0296_y
crossref_primary_10_1007_s11883_012_0268_6
crossref_primary_10_1093_jmcb_mjx037
crossref_primary_10_1161_ATVBAHA_120_314875
crossref_primary_10_1074_jbc_M116_766832
crossref_primary_10_1371_journal_pbio_3000734
crossref_primary_10_3390_ijms242115866
crossref_primary_10_5551_jat_23044
crossref_primary_10_1093_cvr_cvw090
crossref_primary_10_1016_j_mvr_2011_08_001
crossref_primary_10_4161_cam_29026
crossref_primary_10_1038_s41401_024_01285_w
crossref_primary_10_5483_BMBRep_2014_47_10_216
crossref_primary_10_1164_rccm_201102_0327UP
crossref_primary_10_1002_jcp_24523
crossref_primary_10_3390_jcm12227145
crossref_primary_10_1002_jnr_23628
crossref_primary_10_1242_jcs_259468
crossref_primary_10_3390_ijms21041240
crossref_primary_10_1007_s00418_017_1551_y
Cites_doi 10.1074/jbc.R100043200
10.1038/nrc1780
10.1161/circresaha.108.184663
10.1074/jbc.M006323200
10.1152/ajpheart.00403.2006
10.1016/S1357-2725(00)00059-5
10.1016/j.devcel.2009.01.004
10.1038/11926
10.1016/S0968-0004(99)01406-1
10.1073/pnas.0608658103
10.1172/JCI28521
10.1161/circresaha.108.176974
10.1128/MCB.00846-06
10.1158/0008-5472.CAN-07-1302
10.1016/S0092-8674(00)81010-7
10.1161/01.RES.0000267856.00713.0a
10.1242/dev.129.11.2619
10.1074/jbc.M509378200
10.1152/ajpheart.01230.2008
10.1161/circresaha.107.169805
10.1161/circresaha.109.200717
10.1038/sj.onc.1210566
10.1182/blood.V97.6.1679
10.1152/ajpcell.00288.2008
10.1161/circresaha.107.167080
10.1038/sj.onc.1203563
10.1074/jbc.M700078200
10.1167/iovs.08-1811
10.1002/dvdy.20939
10.1016/S0022-2836(02)01449-3
10.1128/MCB.00063-09
10.1016/j.ydbio.2009.07.028
10.1074/jbc.M307631200
10.1161/CIRCRESAHA.108.186064
10.1038/sj.emboj.7601824
10.1128/MCB.26.6.2055-2064.2006
10.1101/gr.2552804
10.1074/jbc.271.49.31384
10.1074/jbc.273.2.1026
10.1152/physrev.00012.2005
10.1161/CIRCRESAHA.107.152736
ContentType Journal Article
Copyright 2010 American Heart Association, Inc.
2015 INIST-CNRS
Copyright_xml – notice: 2010 American Heart Association, Inc.
– notice: 2015 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOI 10.1161/CIRCRESAHA.110.219592
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
CrossRef

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1524-4571
EndPage 966
ExternalDocumentID 10_1161_CIRCRESAHA_110_219592
20724706
23351775
00003012-201010150-00005
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NHLBI NIH HHS
  grantid: T32 HL072742
– fundername: NHLBI NIH HHS
  grantid: HL079356-03S1
– fundername: NIGMS NIH HHS
  grantid: T32 GM070388
– fundername: NHLBI NIH HHS
  grantid: R01HL079356
– fundername: NCRR NIH HHS
  grantid: UL1RR029879
– fundername: NHLBI NIH HHS
  grantid: T32HL072742
– fundername: NCRR NIH HHS
  grantid: UL1 RR029879
– fundername: NIGMS NIH HHS
  grantid: T32GM070388
– fundername: NHLBI NIH HHS
  grantid: T32 HL007829
– fundername: NHLBI NIH HHS
  grantid: T32HL007829
GroupedDBID -
.Z2
01R
0R
1J1
29B
2WC
40H
4Q1
4Q2
4Q3
53G
55
5GY
5RE
5VS
71W
77Y
7O
7O~
AAAXR
AAMOA
AAMTA
AAPBV
AARTV
AAXQO
ABBUW
ABFLS
ABOCM
ABXVJ
ABZAD
ACDDN
ACEWG
ACGFS
ACPRK
ACWDW
ACWRI
ACXNZ
ADACO
ADBBV
ADNKB
AE3
AENEX
AFUWQ
AHMBA
AHULI
AHVBC
AIJEX
AJIOK
AJNYG
AJYGW
ALMA_UNASSIGNED_HOLDINGS
AMJPA
ASCII
AWKKM
BAWUL
BOYCO
BQLVK
C45
CS3
DIK
DU5
DUNZO
E.X
E3Z
EBS
EJD
EX3
F2K
F2L
F2M
F2N
F5P
FL-
FRP
FW0
GX1
H0
H0~
H13
HZ
IKYAY
IN
IN~
J5H
JK3
JK8
K8S
KD2
KMI
KQ8
L-C
L7B
LI0
N9A
N~7
N~B
O0-
O9-
OAG
OAH
OB2
ODA
OHASI
OK1
OL1
OLG
OLH
OLU
OLV
OLW
OLY
OLZ
OPUJH
OUVQU
OVD
OVDNE
OVIDH
OVLEI
OWW
OWY
OXXIT
P2P
PQEST
PQQKQ
RAH
RHF
RLZ
RSW
S4R
S4S
UPT
V2I
WH7
WOQ
WOW
X
X3V
X3W
X7M
Z2
ZA5
---
-~X
.-D
.3C
.55
.GJ
08R
0R~
18M
1CY
41~
AAGIX
AAHPQ
AAQKA
AASOK
AAUGY
ABASU
ABDIG
ABQRW
ACCJW
ACGFO
ACILI
ACNWC
ADFPA
ADGGA
AE6
AEETU
AFDTB
AFFNX
AGINI
AHOMT
AHRYX
AJNWD
AKALU
AKULP
ALMTX
AMKUR
AMNEI
AOHHW
BS7
C1A
DIWNM
EEVPB
FCALG
GNXGY
GQDEL
HZ~
H~9
IKREB
IPNFZ
IQODW
JF9
JG8
MVM
N~M
OCUKA
OJAPA
ORVUJ
OWU
OWV
OWX
OWZ
P-K
R58
RIG
T8P
TEORI
TR2
TSPGW
VVN
W3M
W8F
XXN
XYM
YFH
YOC
ZFV
ZGI
ZZMQN
AAAAV
AAIQE
ABJNI
ADHPY
AHQNM
AINUH
AJZMW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c5515-58eb6747deebe1b54bd988038794729b02a77136360c1d04b4e6bb7962930ab93
ISSN 0009-7330
IngestDate Tue Sep 17 21:22:49 EDT 2024
Fri Aug 16 07:26:34 EDT 2024
Fri Aug 23 01:42:08 EDT 2024
Sat Sep 28 07:47:01 EDT 2024
Sun Oct 22 16:08:17 EDT 2023
Thu Aug 13 19:50:26 EDT 2020
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords Vertebrata
Endothelial cell
endothelial cells
Mammalia
Barrier function
VE-cadherin
Circulatory system
Cadherin
KLF4
WNT
Endothelium
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c5515-58eb6747deebe1b54bd988038794729b02a77136360c1d04b4e6bb7962930ab93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Equal contribution.
OpenAccessLink https://www.ahajournals.org/doi/pdf/10.1161/CIRCRESAHA.110.219592
PMID 20724706
PQID 758837387
PQPubID 23479
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3018700
proquest_miscellaneous_758837387
crossref_primary_10_1161_CIRCRESAHA_110_219592
pubmed_primary_20724706
pascalfrancis_primary_23351775
wolterskluwer_health_00003012-201010150-00005
ProviderPackageCode L-C
C45
7O~
AARTV
OLH
ASCII
OLG
AAMOA
ODA
ABZAD
ABBUW
JK3
ADNKB
JK8
H0~
1J1
OLV
OLU
OLW
OLZ
OLY
F2K
F2M
F2L
F2N
OHASI
AHVBC
AJNYG
FL-
KMI
K8S
OVLEI
AJIOK
OPUJH
V2I
S4R
S4S
4Q1
DUNZO
OAG
4Q2
OVDNE
4Q3
AMJPA
OAH
OVD
71W
AHULI
OB2
ACEWG
.Z2
N~7
IKYAY
OVIDH
AWKKM
40H
N~B
OUVQU
X3V
X3W
ACDDN
ACWRI
BOYCO
AIJEX
AAXQO
AAMTA
AAAXR
E.X
OWW
OWY
01R
ACXNZ
OL1
ABXVJ
IN~
KD2
OXXIT
77Y
ACWDW
FW0
PublicationCentury 2000
PublicationDate 2010-October-15
PublicationDateYYYYMMDD 2010-10-15
PublicationDate_xml – month: 10
  year: 2010
  text: 2010-October-15
  day: 15
PublicationDecade 2010
PublicationPlace Hagerstown, MD
PublicationPlace_xml – name: Hagerstown, MD
– name: United States
PublicationTitle Circulation research
PublicationTitleAlternate Circ Res
PublicationYear 2010
Publisher American Heart Association, Inc
Lippincott Williams & Wilkins
Publisher_xml – name: American Heart Association, Inc
– name: Lippincott Williams & Wilkins
References 10366853 - Trends Biochem Sci. 1999 Jun;24(6):236-40
14627709 - J Biol Chem. 2004 Feb 6;279(6):5035-41
16169848 - J Biol Chem. 2005 Nov 18;280(46):38247-58
16670755 - J Clin Invest. 2006 May;116(5):1150-8
19632219 - Dev Biol. 2009 Oct 1;334(1):243-52
17060454 - Mol Cell Biol. 2007 Jan;27(1):182-94
17209004 - Am J Physiol Heart Circ Physiol. 2007 May;292(5):H2167-75
19168719 - Am J Physiol Heart Circ Physiol. 2009 Apr;296(4):H1027-37
19217423 - Dev Cell. 2009 Feb;16(2):209-21
19901072 - Mol Cell Biol. 2010 Jan;30(2):372-81
9422764 - J Biol Chem. 1998 Jan 9;273(2):1026-31
8940147 - J Biol Chem. 1996 Dec 6;271(49):31384-90
17013885 - Dev Dyn. 2006 Nov;235(11):3110-20
19644057 - Circ Res. 2009 Jul 31;105(3):223-30
12015290 - Development. 2002 Jun;129(11):2619-28
18757824 - Circ Res. 2008 Sep 26;103(7):690-3
10954723 - J Biol Chem. 2000 Dec 1;275(48):37798-806
17130451 - Proc Natl Acad Sci U S A. 2006 Dec 5;103(49):18668-73
16371600 - Physiol Rev. 2006 Jan;86(1):279-367
12581631 - J Mol Biol. 2003 Feb 21;326(3):665-77
17671182 - Cancer Res. 2007 Aug 1;67(15):7147-54
18451337 - Circ Res. 2008 May 23;102(10):1182-91
10431239 - Nat Genet. 1999 Aug;22(4):356-60
10828886 - Oncogene. 2000 May 11;19(20):2438-46
15289477 - Genome Res. 2004 Aug;14(8):1585-93
18420943 - Circ Res. 2008 May 23;102(10):1192-201
17585076 - Circ Res. 2007 Jun 22;100(12):1686-95
17563748 - Oncogene. 2007 Nov 22;26(53):7480-9
18469187 - Invest Ophthalmol Vis Sci. 2008 Aug;49(8):3360-70
17704209 - Circ Res. 2007 Oct 12;101(8):792-801
16507986 - Mol Cell Biol. 2006 Mar;26(6):2055-64
17762869 - EMBO J. 2007 Sep 19;26(18):4138-48
11443140 - J Biol Chem. 2001 Sep 14;276(37):34355-8
18768922 - Am J Physiol Cell Physiol. 2008 Nov;295(5):C1175-82
18483411 - Circ Res. 2008 Jun 20;102(12):1548-57
19168440 - Circ Res. 2009 Mar 13;104(5):609-18
10428027 - Cell. 1999 Jul 23;98(2):147-57
16372018 - Nat Rev Cancer. 2006 Jan;6(1):11-23
11137451 - Int J Biochem Cell Biol. 2000 Nov-Dec;32(11-12):1103-21
11238107 - Blood. 2001 Mar 15;97(6):1679-84
17339326 - J Biol Chem. 2007 May 4;282(18):13769-79
e_1_3_5_28_2
e_1_3_5_27_2
e_1_3_5_26_2
e_1_3_5_25_2
e_1_3_5_24_2
e_1_3_5_23_2
e_1_3_5_22_2
e_1_3_5_21_2
e_1_3_5_29_2
e_1_3_5_2_2
e_1_3_5_40_2
e_1_3_5_41_2
e_1_3_5_42_2
e_1_3_5_8_2
e_1_3_5_20_2
e_1_3_5_7_2
e_1_3_5_9_2
e_1_3_5_4_2
e_1_3_5_3_2
e_1_3_5_6_2
e_1_3_5_5_2
e_1_3_5_17_2
e_1_3_5_39_2
e_1_3_5_16_2
e_1_3_5_38_2
e_1_3_5_15_2
e_1_3_5_37_2
e_1_3_5_14_2
e_1_3_5_36_2
e_1_3_5_12_2
e_1_3_5_35_2
e_1_3_5_13_2
e_1_3_5_34_2
e_1_3_5_10_2
e_1_3_5_33_2
e_1_3_5_11_2
e_1_3_5_32_2
e_1_3_5_19_2
e_1_3_5_18_2
e_1_3_5_31_2
e_1_3_5_30_2
References_xml – ident: e_1_3_5_13_2
  doi: 10.1074/jbc.R100043200
– ident: e_1_3_5_24_2
  doi: 10.1038/nrc1780
– ident: e_1_3_5_35_2
  doi: 10.1161/circresaha.108.184663
– ident: e_1_3_5_17_2
  doi: 10.1074/jbc.M006323200
– ident: e_1_3_5_22_2
  doi: 10.1152/ajpheart.00403.2006
– ident: e_1_3_5_12_2
  doi: 10.1016/S1357-2725(00)00059-5
– ident: e_1_3_5_4_2
  doi: 10.1016/j.devcel.2009.01.004
– ident: e_1_3_5_26_2
  doi: 10.1038/11926
– ident: e_1_3_5_11_2
  doi: 10.1016/S0968-0004(99)01406-1
– ident: e_1_3_5_27_2
  doi: 10.1073/pnas.0608658103
– ident: e_1_3_5_28_2
  doi: 10.1172/JCI28521
– ident: e_1_3_5_18_2
  doi: 10.1161/circresaha.108.176974
– ident: e_1_3_5_31_2
  doi: 10.1128/MCB.00846-06
– ident: e_1_3_5_8_2
  doi: 10.1158/0008-5472.CAN-07-1302
– ident: e_1_3_5_38_2
  doi: 10.1016/S0092-8674(00)81010-7
– ident: e_1_3_5_25_2
  doi: 10.1161/01.RES.0000267856.00713.0a
– ident: e_1_3_5_14_2
  doi: 10.1242/dev.129.11.2619
– ident: e_1_3_5_29_2
  doi: 10.1074/jbc.M509378200
– ident: e_1_3_5_37_2
  doi: 10.1152/ajpheart.01230.2008
– ident: e_1_3_5_42_2
  doi: 10.1161/circresaha.107.169805
– ident: e_1_3_5_5_2
  doi: 10.1161/circresaha.109.200717
– ident: e_1_3_5_40_2
  doi: 10.1038/sj.onc.1210566
– ident: e_1_3_5_2_2
  doi: 10.1182/blood.V97.6.1679
– ident: e_1_3_5_34_2
  doi: 10.1152/ajpcell.00288.2008
– ident: e_1_3_5_41_2
  doi: 10.1161/circresaha.107.167080
– ident: e_1_3_5_39_2
  doi: 10.1038/sj.onc.1203563
– ident: e_1_3_5_21_2
  doi: 10.1074/jbc.M700078200
– ident: e_1_3_5_32_2
  doi: 10.1167/iovs.08-1811
– ident: e_1_3_5_10_2
  doi: 10.1002/dvdy.20939
– ident: e_1_3_5_15_2
  doi: 10.1016/S0022-2836(02)01449-3
– ident: e_1_3_5_9_2
  doi: 10.1128/MCB.00063-09
– ident: e_1_3_5_23_2
  doi: 10.1016/j.ydbio.2009.07.028
– ident: e_1_3_5_16_2
  doi: 10.1074/jbc.M307631200
– ident: e_1_3_5_36_2
  doi: 10.1161/CIRCRESAHA.108.186064
– ident: e_1_3_5_30_2
  doi: 10.1038/sj.emboj.7601824
– ident: e_1_3_5_7_2
  doi: 10.1128/MCB.26.6.2055-2064.2006
– ident: e_1_3_5_20_2
  doi: 10.1101/gr.2552804
– ident: e_1_3_5_6_2
  doi: 10.1074/jbc.271.49.31384
– ident: e_1_3_5_19_2
  doi: 10.1074/jbc.273.2.1026
– ident: e_1_3_5_3_2
  doi: 10.1152/physrev.00012.2005
– ident: e_1_3_5_33_2
  doi: 10.1161/CIRCRESAHA.107.152736
SSID ssj0014329
Score 2.3769207
Snippet RATIONALE:Vascular endothelial (VE)-cadherin localized at adherens junctions (AJs) regulates endothelial barrier function. Because WNT (wingless)...
Vascular endothelial (VE)-cadherin localized at adherens junctions (AJs) regulates endothelial barrier function. Because WNT (wingless) signaling-induced...
Rationale: Vascular endothelial (VE)-cadherin localized at adherens junctions (AJs) regulates endothelial barrier function. Because WNT (wingless)...
RATIONALEVascular endothelial (VE)-cadherin localized at adherens junctions (AJs) regulates endothelial barrier function. Because WNT (wingless)...
SourceID pubmedcentral
proquest
crossref
pubmed
pascalfrancis
wolterskluwer
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 959
SubjectTerms Adherens Junctions - physiology
Animals
Antigens, CD - genetics
Biological and medical sciences
Cadherins - genetics
Capillary Permeability - physiology
Cells, Cultured
Endothelial Cells - immunology
Fundamental and applied biological sciences. Psychology
Gene Expression Regulation - immunology
Humans
Kruppel-Like Transcription Factors - physiology
Lipopolysaccharides - pharmacology
Mice
Mice, Knockout
Neutrophils - cytology
Neutrophils - immunology
Pneumonia - immunology
Pneumonia - metabolism
Pneumonia - physiopathology
Promoter Regions, Genetic - physiology
Signal Transduction - immunology
Umbilical Veins - cytology
Vertebrates: cardiovascular system
Wnt Proteins - metabolism
Wnt Proteins - pharmacology
Wnt3 Protein
Title Krüppel-Like Factor-4 Transcriptionally Regulates VE-Cadherin Expression and Endothelial Barrier Function
URI http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00003012-201010150-00005
https://www.ncbi.nlm.nih.gov/pubmed/20724706
https://search.proquest.com/docview/758837387
https://pubmed.ncbi.nlm.nih.gov/PMC3018700
Volume 107
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9pAEF7RVKoqRVXfpY_Ih97QUj92vfbRQVBSQqJGoY16sXbtRaVBBkGiSv1t7al_rDO7fkCD1MfFAhuzmPl2ZnZ25htCXsdKyyCPQspiJSl4xDGVTIc00x7PoiibKo0B_fFJOJywdxf8otX6sZG1dH2lutm3nXUl_yNVOAdyxSrZf5Bs_aVwAl6DfOEIEobjX8l4ZPa5D3vLpZ7T49ml7gxM-xzKLGl5pRHkfI6utuk6r9edD33ak7kp_EOqY5sJa5OS-0WOJVlzjKMfypVpZzcA01eLryI1mK2ysvFXp-QLquPKvdOPiUkeMEEJXTTFDqPT4bHNvOibsWsvevLW3gG_OgMl1ZiBZHyWnHTGR2efkiZ0WwYpMOHDpbZM0wYpdpBNmCDFbI6ZQFsKOqYiKLdqdKmTfUYZt51aaqVte-WW6Iw2VHBcMoxbax7bni43DUWIhqJ3dNYDoCfDBMshuj4y7fiNZayyAX4zmHUaox8E3BOC3yK3fRFzXPuP3jebWCzw46qRHz5TWUAGQ7_ZOfCWa7S_lGuYpVPbXmXX-udmGu_-1wWmWKwvTYXFhp90fp_cKxc4TmLR-oC0dPGQ3BmXKRyPyJfR6uf3GrBOBVjnBmCdGrDOBmCdBrAOANbZAKxTAtapAPuYTAb9896Qlg0_aAaOO6c80iqE9W2uQbV4ijOVx2BfAtAgDBaByvWlEF6AFHeZl7tMgVZRSsQh-KyuVHHwhOwVi0I_I47IhB9xrVkuI8anXqx9nnFXstyXcEm0Sbf6r9Ol5XVJzXo49NJGOPDeTa1w2uRgSyL1XRUI2sSpRJSCisZ9N1noxfU6hSV5hARiMOhTK7HmZlf4TLhhm4gtWdYfQPb37SvF7LNhgQ-wnabrtgndknpq66cxqQSjHT7F6ehhXBMJJFz-_E_P8YLcRc5OM4PFS7J3tbrWr8DxvlIHBt6_AGm_1lI
link.rule.ids 230,315,786,790,891,27957,27958
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Kr%C3%BCppel-Like+Factor-4+Transcriptionally+Regulates+VE-Cadherin+Expression+and+Endothelial+Barrier+Function&rft.jtitle=Circulation+research&rft.au=COWAN%2C+Colleen+E&rft.au=KOHLER%2C+Erin+E&rft.au=DUGAN%2C+Tracey+A&rft.au=KAMRAN+MIRZA%2C+M&rft.date=2010-10-15&rft.pub=Lippincott+Williams+%26+Wilkins&rft.issn=0009-7330&rft.eissn=1524-4571&rft.volume=107&rft.issue=8&rft.spage=959&rft.epage=966&rft_id=info:doi/10.1161%2FCIRCRESAHA.110.219592&rft.externalDBID=n%2Fa&rft.externalDocID=23351775
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-7330&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-7330&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-7330&client=summon